Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
News
Events
Contact us
News
Long-acting oral combo for HIV maintains viral suppression at Week 24
19 April 2024
Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies
19 April 2024
Long-acting injectable for schizophrenia approved in the EU
12 April 2024
Positive phase 2 study of zilebesiran for patients with hypertension
12 April 2024
Innovative Long-acting Drug Delivery Platform Implanted in Eyes
05 April 2024
Medicenna Announce First Patient with Advanced Solid Tumours Dosed in ABILITY-1 Study of MDNA11 Combination with KEYTRUDA® (pembrolizumab)
16 February 2024
Long-acting antiretroviral therapy (ART) maintains HIV virologic suppression regardless of obesity status
16 February 2024
Long-acting HIV Antiretrovirals adopted in Botswana
09 February 2024
Global Long-acting Therapeutics News from January 2024
29 January 2024
Newer stories
Older Stories